We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

199 hedge funds and large institutions have $6.8B invested in BeOne Medicines Ltd in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

25% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 56

4% more funds holding

Funds holding: 192 → 199 (+7)

2% more capital invested

Capital invested by funds: $6.65B → $6.8B (+$146M)

0.15% more ownership

Funds ownership: 6.18% → 6.33% (+0.15%)

17% less call options, than puts

Call options by funds: $9.84M | Put options by funds: $11.8M

36% less funds holding in top 10

Funds holding in top 10: 14 → 9 (-5)

Holders
199
Holders Change
+7
Holders Change %
+3.65%
% of All Funds
4.31%
Holding in Top 10
9
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-35.71%
% of All Funds
0.19%
New
32
Increased
70
Reduced
56
Closed
25
Calls
$9.84M
Puts
$11.8M
Net Calls
-$1.99M
Net Calls Change
-$31.6M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$110M
2
CGT
Capital Guardian Trust
California
+$50.5M
3
VanEck Associates
VanEck Associates
New York
+$17.1M
4
CII
Capital International Inc
California
+$15.8M
5
Russell Investments Group
Russell Investments Group
United Kingdom
+$15.4M

Top Sellers

1
MAM
Myriad Asset Management
Hong Kong
-$23.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$19.9M
3
ICP
Indus Capital Partners
New York
-$19.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.7M
5
Morgan Stanley
Morgan Stanley
New York
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$37.3M +$4.13M +30,577 +12%
O
27
OrbiMed
New York
$37.3M – – –
Victory Capital Management
28
Victory Capital Management
Texas
$32.9M +$3.29M +24,350 +11%
Sands Capital Management
29
Sands Capital Management
Virginia
$31.8M -$585K -4,339 -2%
Rockefeller Capital Management
30
Rockefeller Capital Management
New York
$31.3M +$1.14M +8,478 +4%
MICM
31
Matthews International Capital Management
California
$30.8M -$1.32M -9,800 -4%
Legal & General Group
32
Legal & General Group
United Kingdom
$28.5M +$5.67M +42,053 +24%
RSCM
33
Rock Springs Capital Management
Maryland
$28.4M – – –
Fiera Capital (Canada)
34
Fiera Capital (Canada)
Quebec, Canada
$27.2M -$1.26M -9,302 -4%
Bank of America
35
Bank of America
North Carolina
$26.1M +$12M +89,201 +82%
Morgan Stanley
36
Morgan Stanley
New York
$25.8M -$16.5M -122,253 -38%
CS
37
Candriam SCA
Luxembourg
$24.2M +$4.78M +35,444 +24%
CBT
38
Capital Bank & Trust
California
$22.9M +$15.3M +113,401 +186%
WRF
39
Waddell & Reed Financial
Kansas
$20.9M – – –
Geode Capital Management
40
Geode Capital Management
Massachusetts
$18.1M +$651K +4,823 +4%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$18.1M -$303K -2,246 -2%
VanEck Associates
42
VanEck Associates
New York
$16.8M +$17.1M +126,926 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$15.9M +$189K +1,400 +1%
UBS AM
44
UBS AM
Illinois
$14.7M +$1.06M +7,826 +8%
Macquarie Group
45
Macquarie Group
Australia
$14.1M -$661K -4,900 -4%
CIS
46
Capital International Sarl
California
$13.8M +$5.07M +37,600 +56%
BG
47
Bellevue Group
Switzerland
$13.5M +$2.51M +18,600 +22%
Nordea Investment Management
48
Nordea Investment Management
Sweden
$13.2M -$67.5K -500 -0.5%
PC
49
Polar Capital
United Kingdom
$13.2M -$8.1M -60,000 -38%
Baillie Gifford & Co
50
Baillie Gifford & Co
United Kingdom
$12.6M +$116K +858 +0.9%
1
2
3 4 5

ONC Hedge Fund Activity: Q1 2019 in Review

199 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2019, worth a combined $6.8B — up 2.2% from $6.65B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ONC positions and 25 closed out — a net gain of 7 holders — while 70 added to existing stakes and 56 trimmed.

The largest buyer was Capital International Investors, adding an estimated $110M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $23.3M sold.

  • 199 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2019, up from 192 in Q4 2018.
  • Funds reported $6.8B of BeOne Medicines Ltd stock for Q1 2019, up 2.2% quarter-over-quarter.
  • 32 funds opened new BeOne Medicines Ltd positions in Q1 2019 and 25 closed out, a net change of +7 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2019 was Capital International Investors, an estimated $110M added.
  • The largest BeOne Medicines Ltd seller in Q1 2019 was Myriad Asset Management, an estimated $23.3M sold.

Based on aggregated 13F filings for Q1 2019.